Literature DB >> 2992209

Calcium metabolism in paravertebral ligamentous ossification.

Y Takuwa, T Matsumoto, T Kurokawa, M Iizuka, Y Hoshino, K Hata, E Ogata.   

Abstract

Twenty-eight patients with paravertebral ligamentous ossification (PVLO) and 11 control subjects were studied in an attempt to examine possible involvement of disturbances in mineral metabolism in the development of PVLO. No significant difference in baseline serum calcium and fasting urinary calcium excretion was found between patients with PVLO and controls. Patients with PVLO showed lower serum inorganic phosphate (Pi) and tubular reabsorptive capacity for Pi (TmP/GFR) than controls. Basal nephrogenous cyclic 3',5'-AMP (NcAMP) was elevated in some patients with PVLO. A significant inverse relationship was found between basal TmP/GFR and NcAMP in patients with PVLO (r = -0.50; P less than 0.01). Compared with controls, patients with PVLO had significantly lower calciuric responses to an oral calcium load (P less than 0.05), suggesting decreased intestinal calcium absorption. Furthermore, a significant inverse correlation was found between basal NcAMP and the calciuric response in patients with PVLO (r = -0.42; P less than 0.05). Serum 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels were not significantly different between the two groups. The size of ossified areas in paravertebral ligaments estimated from spinal radiograms inversely correlated with the calciuric response to the oral calcium load (r = -0.50; P less than 0.01). These data demonstrate that the development of PVLO is associated with decreased intestinal calcium absorption in the face of normal serum 1,25(OH)2D level. Thus, together with previous observations showing a high incidence of PVLO in patients with hypoparathyroidism or familial hypophosphataemic rickets/osteomalacia, the present results suggest that the defect in the action of 1,25(OH)2D may underlie the development of PVLO.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992209     DOI: 10.1530/acta.0.1090428

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

1.  Associated factors for and progression rate of sacroiliac joint degeneration in subjects undergoing comprehensive medical checkups.

Authors:  Yusuke Sato; Kosuke Kashiwabara; Yuki Taniguchi; Yoshitaka Matsubayashi; So Kato; Toru Doi; Shima Hirai; Naohiro Tachibana; Hiroyuki Hasebe; Koji Nakajima; Naoto Hayashi; Sakae Tanaka; Yasushi Oshima
Journal:  Eur Spine J       Date:  2019-10-01       Impact factor: 3.134

Review 2.  Biomarker Research Approach to the Pathogenesis of Ossification of the Spinal Ligament: A Review.

Authors:  Yoshiharu Kawaguchi
Journal:  Spine Surg Relat Res       Date:  2022-04-12

Review 3.  Hormones and growth factors in the pathogenesis of spinal ligament ossification.

Authors:  Hai Li; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Eur Spine J       Date:  2007-04-11       Impact factor: 3.134

4.  Anterior decompression and fusion for cervical myeloradiculopathy secondary to ossification of the posterior ligament.

Authors:  H Baba; N Furusawa; Y Tanaka; M Wada; S Imura; K Tomita
Journal:  Int Orthop       Date:  1994       Impact factor: 3.075

5.  Spondyloarthropathy occurring in long-standing idiopathic hypoparathyroidism.

Authors:  Ravi Kanth Jakkani; Jyoti Sureka; John Mathew
Journal:  Radiol Case Rep       Date:  2015-11-06

6.  Serum biomarkers in patients with ossification of the posterior longitudinal ligament (OPLL): Inflammation in OPLL.

Authors:  Yoshiharu Kawaguchi; Masato Nakano; Taketoshi Yasuda; Shoji Seki; Kayo Suzuki; Yasuhito Yahara; Hiroto Makino; Isao Kitajima; Tomoatsu Kimura
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

Review 7.  Biomarkers of Ossification of the Spinal Ligament.

Authors:  Yoshiharu Kawaguchi
Journal:  Global Spine J       Date:  2018-07-26

8.  Association of bone morphogenetic protein-2 gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity in Chinese patients.

Authors:  Hao Wang; Dongmei Liu; Zhaohui Yang; Baopeng Tian; Jie Li; Xianglong Meng; Zhentian Wang; Hui Yang; Xin Lin
Journal:  Eur Spine J       Date:  2008-04-04       Impact factor: 3.134

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.